Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash $ 7,150,695 $ 10,950,927
Prepaid expenses and other current assets 268,677 554,321
Australia research and development incentives receivable 144,680 302,789
Total current assets 7,564,052 11,808,037
Deferred offering costs 0 211,203
Other assets 2,800 2,800
Total assets 7,566,852 12,022,040
Current liabilities:    
Accounts payable 1,638,546 1,165,505
Accrued expenses 3,298,607 2,103,401
Total current liabilities 4,937,153 3,268,906
Long term liabilities:    
Warrant liability 2,152,188 245,341
Total liabilities 7,089,341 3,514,247
Commitments and contingencies (Note 7)
Stockholders' equity (deficit)    
Preferred stock, $0.0001 par value, 30,000,000 shares authorized at December 31, 2023 and December 31, 2022, 0 shares issued and outstanding
Common stock, $0.0001 par value, 70,000,000 shares authorized at December 31, 2023 and December 31, 2022, 16,986,254 and 10,955,904 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively 1,699 1,096
Additional paid-in capital 64,472,249 52,729,942
Accumulated deficit (63,980,177) (44,207,272)
Accumulated other comprehensive loss (16,260) (15,973)
Total stockholders' equity 477,511 8,507,793
Total liabilities and stockholders' equity $ 7,566,852 $ 12,022,040